{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:50:13Z","timestamp":1790502613077,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.vaccine.2019.09.052","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T18:09:24Z","timestamp":1569348564000},"page":"6907-6914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014\u20132017"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1766-0657","authenticated-orcid":false,"given":"Eric P.F.","family":"Chow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-4175","authenticated-orcid":false,"given":"Sepehr N.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-8085","authenticated-orcid":false,"given":"Dorothy A.","family":"Machalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2893-0969","authenticated-orcid":false,"given":"David G.","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane S.","family":"Hocking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0806-8475","authenticated-orcid":false,"given":"Alyssa M.","family":"Cornall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steph","family":"Atchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona S.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren B.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7639-4355","authenticated-orcid":false,"given":"John M.","family":"Kaldor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2019.09.052_b0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/jpc.12627","article-title":"Human papillomavirus vaccination: where are we now?","volume":"50","author":"Brotherton","year":"2014","journal-title":"J Paediatr Child Health"},{"issue":"41","key":"10.1016\/j.vaccine.2019.09.052_b0010","doi-asserted-by":"crossref","first-page":"1700737","DOI":"10.2807\/1560-7917.ES.2018.23.41.1700737","article-title":"The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?","volume":"23","author":"Patel","year":"2018","journal-title":"Eurosurveillance"},{"issue":"7","key":"10.1016\/j.vaccine.2019.09.052_b0015","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.vaccine.2019.09.052_b0020","unstructured":"National HPV Vaccination Program Register. National (Australia) HPV 3 dose vaccination coverage for females turning 15 years of age in 2017 2018 [2 January 2019]. Available from: http:\/\/www.hpvregister.org.au\/research\/coverage-data\/HPV-Vaccination-Coverage-2017."},{"key":"10.1016\/j.vaccine.2019.09.052_b0025","unstructured":"National HPV Vaccination Program Register. National (Australia) HPV 3 dose vaccination coverage for males turning 15 years of age in 2017 2018 [2 January 2019]. Available from: http:\/\/www.hpvregister.org.au\/research\/coverage-data\/HPV-Vaccination-Coverage-2017---Male."},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.052_b0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.33321\/cdi.2011.35.18","article-title":"Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18\u201326 years from the National HPV Vaccination Program Register","volume":"35","author":"Brotherton","year":"2011","journal-title":"Commun Dis Intell Quart Rep"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.052_b0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/sextrans-2014-051813","article-title":"Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme","volume":"91","author":"Chow","year":"2015","journal-title":"Sexual Transm Infect"},{"key":"10.1016\/j.vaccine.2019.09.052_b0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f2032","article-title":"Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data","volume":"346","author":"Ali","year":"2013","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.052_b0045","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S1473-3099(15)00055-9","article-title":"Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study","volume":"15","author":"Chow","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.052_b0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1071\/SH10001","article-title":"Measuring human papillomavirus (HPV) vaccination coverage and the role of the National HPV Vaccination Program Register, Australia","volume":"8","author":"Gertig","year":"2011","journal-title":"Sexual Health"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.052_b0055","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1473-3099(16)30116-5","article-title":"Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study","volume":"17","author":"Chow","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.052_b0060","first-page":"202","article-title":"Human Papillomavirus Prevalence in Unvaccinated Heterosexual Men After a National Female Vaccination Program","volume":"215","author":"Machalek","year":"2017","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.052_b0065","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/OLQ.0000000000000030","article-title":"Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males","volume":"40","author":"Korostil","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"48","key":"10.1016\/j.vaccine.2019.09.052_b0070","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1016\/j.vaccine.2011.02.091","article-title":"The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia","volume":"29","author":"Smith","year":"2011","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.vaccine.2019.09.052_b0075","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1016\/j.vaccine.2017.07.078","article-title":"Targeted human papillomavirus vaccination for young men who have sex with men in Australia yields significant population benefits and is cost-effective","volume":"35","author":"Zhang","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.052_b0080","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S2468-2667(16)30001-9","article-title":"Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models","volume":"1","author":"Brisson","year":"2016","journal-title":"Lancet Public Health"},{"issue":"10197","key":"10.1016\/j.vaccine.2019.09.052_b0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.052_b0090","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/ijc.31119","article-title":"Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I)","volume":"142","author":"Lehtinen","year":"2018","journal-title":"Int J Cancer"},{"issue":"10","key":"10.1016\/j.vaccine.2019.09.052_b0095","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1473-3099(14)70841-2","article-title":"Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study","volume":"14","author":"Tabrizi","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2019.09.052_b0100","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/jnci\/82.18.1477","article-title":"Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers","volume":"82","author":"Resnick","year":"1990","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.052_b0105","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","article-title":"Improved amplification of genital human papillomaviruses","volume":"38","author":"Gravitt","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.052_b0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1525-1438.1996.06030193.x","article-title":"Cervical adenoid basal carcinoma, five cases and literature review","volume":"6","author":"Layton-Henry","year":"1996","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.052_b0115","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1128\/JCM.01169-08","article-title":"Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test","volume":"46","author":"Stevens","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.052_b0120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jviromet.2007.09.018","article-title":"Development and validation of a real-time PCR assay specifically detecting human papillomavirus 52 using the Roche LightCycler 480 system","volume":"147","author":"Stevens","year":"2008","journal-title":"J Virol Methods"},{"issue":"26","key":"10.1016\/j.vaccine.2019.09.052_b0125","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1016\/j.vaccine.2012.04.006","article-title":"Prevalence of human papillomavirus (HPV) infections in sexually active adolescents and young women in England, prior to widespread HPV immunisation","volume":"30","author":"Howell-Jones","year":"2012","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.052_b0130","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1002\/ijc.23670","article-title":"Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland","volume":"123","author":"Leinonen","year":"2008","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.052_b0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1158\/1055-9965.EPI-12-1003","article-title":"High-throughput monitoring of human papillomavirus type distribution","volume":"22","author":"Soderlund-Strand","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.vaccine.2019.09.052_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.pvr.2019.100177","article-title":"Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis","volume":"8","author":"Brotherton","year":"2019","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.vaccine.2019.09.052_b0145","article-title":"Assortative sexual mixing among heterosexuals in Australia: implications for herd protection in males from a female human papillomavirus vaccination program","author":"Chow","year":"2016","journal-title":"Sexual Health"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.052_b0150","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1071\/SH16055","article-title":"Assortative sexual mixing patterns in male-female and male-male partnerships in Melbourne, Australia: implications for HIV and sexually transmissible infection transmission","volume":"13","author":"Chow","year":"2016","journal-title":"Sexual Health"},{"key":"10.1016\/j.vaccine.2019.09.052_b0155","unstructured":"National HPV Vaccination Program Register. HPV Vaccination Coverage by Dose 2017 - Males: HPV vaccination coverage by dose number (Australia) for males by age group in mid 2017 2018 [2 January 2019]. Available from: http:\/\/www.hpvregister.org.au\/research\/coverage-data\/HPV-vaccination-coverage-by-dose-2017---Males."},{"issue":"10","key":"10.1016\/j.vaccine.2019.09.052_b0160","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3201\/eid2210.160675","article-title":"Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes","volume":"22","author":"Mesher","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.09.052_b0165","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/infdis\/jiy432","article-title":"Substantial decline in prevalence of vaccine-type and nonvaccine-type human papillomavirus (HPV) in vaccinated and unvaccinated girls 5 years after implementing HPV vaccine in Norway","volume":"218","author":"Feiring","year":"2018","journal-title":"J Infect Dis"},{"issue":"47","key":"10.1016\/j.vaccine.2019.09.052_b0170","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1016\/j.vaccine.2011.09.021","article-title":"Neutralization of non-vaccine human papillomavirus pseudoviruses from the A7 and A9 species groups by bivalent HPV vaccine sera","volume":"29","author":"Draper","year":"2011","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.052_b0175","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.vaccine.2011.01.001","article-title":"HPV16\/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection","volume":"29","author":"Kemp","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.09.052_b0180","doi-asserted-by":"crossref","first-page":"376","DOI":"10.31128\/AJGP-01-18-4446","article-title":"General practitioners' perspectives on promoting sexual health to young men","volume":"47","author":"Collyer","year":"2018","journal-title":"Aust J Gener Pract"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.052_b0185","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1136\/sti.2008.033068","article-title":"Self-collection of genital human papillomavirus specimens in heterosexual men","volume":"85","author":"Ogilvie","year":"2009","journal-title":"Sexual Transm Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2019.09.052_b0190","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1086\/521629","article-title":"The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study","volume":"196","author":"Giuliano","year":"2007","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.052_b0195","first-page":"101","article-title":"New digital media interventions for sexual health promotion among young people: a systematic review","volume":"16","author":"Wadham","year":"2019","journal-title":"Sexual Health"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.052_b0200","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.vaccine.2013.11.075","article-title":"Human papillomavirus (HPV) vaccination coverage in young Australian women is higher than previously estimated: independent estimates from a nationally representative mobile phone survey","volume":"32","author":"Brotherton","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.052_b0205","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/infdis\/jit626","article-title":"Early acquisition of anogenital human papillomavirus among teenage men who have sex with men","volume":"209","author":"Zou","year":"2014","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.052_b0210","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1473-3099(14)70994-6","article-title":"Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study","volume":"15","author":"Zou","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"43","key":"10.1016\/j.vaccine.2019.09.052_b0215","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1016\/j.vaccine.2019.08.066","article-title":"Anal human papillomavirus infections in young unvaccinated men who have sex with men attending a sexual health clinic for HPV vaccination in Melbourne, Australia","volume":"37","author":"Chow","year":"2019","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19312617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19312617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:35:29Z","timestamp":1759401329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19312617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":43,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0264410X19312617"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014\u20132017","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}